Aviva PLC Boston Scientific Corp Transaction History

Aviva PLC

$36.8 Billion
Q3 2024

A detailed history of Aviva PLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Aviva PLC holds 536,158 shares of BSX stock, worth $48.3 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

536,158

Previous 518,155 3.47%

Holding current value

$48.3 Million

Previous $39.9 Million 12.6%

% of portfolio

0.12%

Previous 0.12%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$72.96 - $84.0 $1.31 Million - $1.51 Million	18,003 Added 3.47%	536,158 $44.9 Million
Q2 2024 Aug 02, 2024	BUY	$67.33 - $77.71 $7.62 Million - $8.79 Million	113,112 Added 27.93%	518,155 $39.9 Million
Q1 2024 May 14, 2024	BUY	$57.6 - $68.62 $1.59 Million - $1.9 Million	27,670 Added 7.33%	405,043 $27.7 Million
Q4 2023 Feb 09, 2024	BUY	$48.64 - $57.81 $2.16 Million - $2.56 Million	44,339 Added 13.31%	377,373 $21.8 Million
Q3 2023 Nov 13, 2023	SELL	$50.19 - $54.68 $1.08 Million - $1.17 Million	-21,479 Reduced 6.06%	333,034 $17.6 Million
Q2 2023 Aug 10, 2023	BUY	$49.72 - $54.64 $6.07 Million - $6.67 Million	122,033 Added 52.49%	354,513 $19.2 Million
Q1 2023 May 12, 2023	SELL	$45.09 - $50.03 $4.23 Million - $4.7 Million	-93,883 Reduced 28.77%	232,480 $11.6 Million
Q4 2022 Feb 09, 2023	SELL	$39.56 - $47.22 $4.24 Million - $5.06 Million	-107,133 Reduced 24.71%	326,363 $15.1 Million
Q3 2022 Nov 14, 2022	BUY	$36.71 - $109.66 $6.53 Million - $19.5 Million	177,821 Added 69.55%	433,496 $16.8 Million
Q2 2022 Aug 04, 2022	SELL	$35.24 - $47.1 $3.22 Million - $4.31 Million	-91,435 Reduced 26.34%	255,675 $9.53 Million
Q1 2022 May 13, 2022	SELL	$40.9 - $45.1 $3.98 Million - $4.38 Million	-97,209 Reduced 21.88%	347,110 $15.4 Million
Q4 2021 Feb 10, 2022	SELL	$38.07 - $44.87 $20.1 Million - $23.7 Million	-527,842 Reduced 54.3%	444,319 $18.9 Million
Q3 2021 Nov 12, 2021	SELL	$41.23 - $45.88 $1.04 Million - $1.16 Million	-25,252 Reduced 2.53%	972,161 $42.2 Million
Q2 2021 Aug 10, 2021	SELL	$38.58 - $44.24 $642,665 - $736,949	-16,658 Reduced 1.64%	997,413 $42.6 Million
Q1 2021 May 13, 2021	BUY	$35.27 - $39.67 $240,611 - $270,628	6,822 Added 0.68%	1,014,071 $39.2 Million
Q4 2020 Feb 10, 2021	BUY	$33.15 - $41.97 $407,645 - $516,105	12,297 Added 1.24%	1,007,249 $36.2 Million
Q3 2020 Nov 12, 2020	SELL	$34.44 - $42.23 $307,239 - $376,733	-8,921 Reduced 0.89%	994,952 $38 Million
Q2 2020 Aug 13, 2020	BUY	$30.19 - $39.11 $20.6 Million - $26.6 Million	680,778 Added 210.71%	1,003,873 $35.2 Million
Q1 2020 May 14, 2020	SELL	$25.83 - $45.71 $201,474 - $356,538	-7,800 Reduced 2.36%	323,095 $10.5 Million
Q4 2019 Feb 10, 2020	SELL	$37.87 - $45.37 $603,041 - $722,471	-15,924 Reduced 4.59%	330,895 $15 Million
Q3 2019 Nov 12, 2019	SELL	$40.31 - $43.45 $6.55 Million - $7.06 Million	-162,551 Reduced 31.91%	346,819 $14.1 Million
Q2 2019 Jul 30, 2019	SELL	$34.91 - $42.98 $410,367 - $505,229	-11,755 Reduced 2.26%	509,370 $21.9 Million
Q1 2019 May 14, 2019	BUY	$32.91 - $40.75 $27,381 - $33,904	832 Added 0.16%	521,125 $20 Million
Q4 2018 Feb 12, 2019	SELL	$31.73 - $39.04 $4.71 Million - $5.79 Million	-148,360 Reduced 22.19%	520,293 $18.4 Million
Q3 2018 Nov 13, 2018	SELL	$32.83 - $38.63 $784,374 - $922,947	-23,892 Reduced 3.45%	668,653 $25.7 Million
Q2 2018 Aug 01, 2018	SELL	$26.84 - $34.32 $134,226 - $171,634	-5,001 Reduced 0.72%	692,545 $22.6 Million
Q1 2018 May 14, 2018	SELL	$25.2 - $28.54 $1.51 Million - $1.71 Million	-59,759 Reduced 7.89%	697,546 $19.1 Million
Q4 2017 Feb 13, 2018	SELL	$24.79 - $29.8 $2.61 Million - $3.13 Million	-105,083 Reduced 12.19%	757,305 $18.8 Million
Q3 2017 Nov 13, 2017	BUY	$26.26 - $29.17 $237,915 - $264,280	9,060 Added 1.06%	862,388 $25.2 Million
Q2 2017 Aug 07, 2017	BUY	N/A	853,328	853,328 $23.7 Million

Others Institutions Holding BSX

# of Institutions

1,539

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $129B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.

Account